Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Wang, Feng ^a   Xu, Rui Hua ^a   Luo, Hui Yan ^a   Zhang, Dong Shen ^a   Jiang, Wen Qi ^a   Huang, Hui Qiang ^a   Sun, Xiao Fei ^a   Xia, Zhong Jun ^a   Guan, Zhong Zhen ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE; GLYCYRRHIZIC ACID DERIVATIVE; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PHOSPHATIDYLCHOLINE; POLYENE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; ONSET AGE; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; BLOOD; CHINA; COMORBIDITY; COMPARATIVE STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; SEX RATIO; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHINA; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER FUNCTION TESTS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43649108786     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-115     Document Type: Article

References (34)

1. Sun Z Ming L Zhu X Lu J Prevention and control of hepatitis B in China J Med Virol 2002, 67:447-450. 10.1002/jmv.10094 12116043
2. Marcucci F Mele A Spada E Candido A Bianco E Pulsoni A Chionne P Madonna E Cotichini R Barbui A Renzo AD Dore F Iannitto E Liso V Martino B Montanaro M Pagano L Musto P Rapicetta M High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma Haematologica 2006, 91:554-557. 16585021
3. Kuniyoshi M Nakamuta M Sakai H Enjoji M Kinukawa N Kotoh K Fukutomi M Yokota M Nishi H Iwamoto H Uike N Nishimura J Inaba S Maeda Y Nawata H Muta K Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma J Gastroenterol Hepatol 2001, 16:215-219. 10.1046/ j.1440-1746.2001.02406.x 11207904
4. Wang F Xu RH Han B Shi YX Luo HY Jiang WQ Lin TY Huang HQ Xia ZJ Guan ZZ High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers Cancer 2007, 109:1360-1364. 10.1002/cncr.22549 17326056
5. Galun E Ilan Y Livni N Ketzinel M Nahor O Pizov G Nagler A Eid A Rivkind A Laster M Hepatitis B virus infection associated with hematopoietic tumors Ann J Pathol 1994, 145:1001-1007. 7977632 1887425
6. Yeo W Chan PK Zhong S Ho WM Steinberg JL Tam JS Hui P Leung NW Zee B Johnson PJ Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors J Med Virol 2000, 62:299-307. 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0 11055239
7. Vento S Cainelli F Longhi MS Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: An unresolved issue Lancet Oncol 2002, 3:333-340. 10.1016/S1470-2045(02)00773-8 12107020
8. Skrabs C Müller C Agis H Mannhalter C Jäger U Treatment of HBV-carrying lymphomoa patients with rituximab and CHOP: A diagnostic and therapeutic challenge Leukemia 2002, 16:1884-1886. 10.1038/ sj.leu.2402567 12200717
9. Su WP Wen CC Hsiung CA Su IJ Cheng AL Chang MC Tsao CJ Kao WY Uen WC Hsu C Hsu CH Lu YS Tien HF Chao TY Chen LT Whang-Peng J Chen PJ Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients World J Gastronenterol 2005, 11:5283-5288. 16149133
10. Cheng AL Hsiung CA Su IJ Chen PJ Chang MC Tsao CJ Kao WY Uen WC Hsu CH Tien HF Chao TY Chen LT Whang-Peng J Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with Lymphoma Hepatology 2003, 37:1320-1328. 10.1053/jhep.2003.50220 12774010
11. Leaw SJ Yen CJ Huang WT Chen TY Su WC Tsao CJ Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy Ann Hematol 2004, 83:270-275. 10.1007/s00277-003-0825-8 15060745
12. Dienstag JL Perrillo RP Schiff ER Bartholomew M Vicary C Rubin M A preliminary trial of lamivudine for chronic hepatitis B infection N Engl J Med 1995, 333:1657-1661. 10.1056/NEJM199512213332501 7477217
13. Persico M De Marino F Russo GD Morante A Rotoli B Torella R De Renzo A Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma Blood 2002, 99:724-725. 10.1182/blood.V99.2.724 11799967
14. Yeo W Chan PK Ho WM Zee B Lam KC Lei KI Chan AT Mok TS Lee JJ Leung TW Zhong S Johnson PJ Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy J Clin Oncol 2004, 22:927-934. 10.1200/ JCO.2004.05.161 14990649
15. Rossi G Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HBsAg carriers with hemato-oncological neoplasias treated with chemotherapy Leuk Lymphoma 2003, 44:759-766. 10.1080/104281903100006351 12802911
16. Li YH He YF Jiang WQ Wang FH Lin XB Zhang L Xia ZJ Sun XF Huang HQ Lin TY He YJ Guan ZZ Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma Cancer 2006, 106:1320-1325. 10.1002/cncr.21701 16470607
17. Cheson BD Horning SJ Coiffier B Shipp MA Fisher RI Connors JM Lister TA Vose J Grillo-López A Hagenbeek A Cabanillas F Klippensten D Hiddemann W Castellino R Harris NL Armitage JO Carter W Hoppe R Canellos GP Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas J Clin Oncol NCI Sponsored International Working Group 1999, 17:1244. 10561185
18. Zhang MZ Wu GY Sun ZC He Z Li X Geng L An analysis of HBV infection in Non-hodgkin lymphoma patients Chin J Basic Clin Oncology 2006, 19:467-468.
19. He H Zhai M Zhang D Clinical significance of detecting serum label of hepatitis B virus in NHL patients J Chin Clin Med 2003, 4:8-10.
20. Lok AS Liang RH Chiu EK Wong KL Chan TK Todd D Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 1991, 100:182-188. 1983820
21. Soon TL Gao F Richard Q Lay CL Lai HL Swee PY Susan L Miriam T The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis Eur J Haematol 79:132-137. 17635237
22. Park SH Lee Y Han SH Kwon SY Kwon OS Kim SS Kim JH Park YH Lee JN Bang SM Cho EK Shin DB Lee JH Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma BMC Cancer 2006, 6:3. 1352374 16396674 10.1186/1471-2407-6-3
23. Faggioli P De Paschale M Tocci A Luoni M Fava S De Paoli A Tosi A Cassi E Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma Haematologica 1997, 82:38-42. 9107080
24. Dai MS Lu JJ Chen YC Perng CL Chao TY Reactivation of Precore Mutant Hepatitis B Virus in Chemotherapy-Treated Patients Cancer 2001, 92:2927-2932. 10.1002/ 1097-0142(20011201)92:11<2927::AID-CNCR10109>3.0.CO;2-W 11753968
25. Hui CK Bowden S Jackson K Au WY Fong DY Lie AK Chim CS Liang R Lau GK Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy Blood 2005, 105:2616-2617. 10.1182/ blood-2004-09-3402 15746088
26. Steinberg JL Yeo W Zhong S Chan JY Tam JS Chan PK Leung NW Johnson PJ Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: Precore/core mutations may play an important role J Med Virol 2000, 60:249-255. 10.1002/ (SICI)1096-9071(200003)60:3<249::AID-JMV1>3.0.CO;2-C 10630955
27. Carman WF Korula J Wallace L MacPhee R Mimms L Decker R Fulminant reactivation of hepatitis B due to envelope protein mutant that escape detection by monoclonal HBsAg ELISA Lancet 1995, 345:1406-1407. 10.1016/ S0140-6736(95)92599-6 7539089
28. Kolk van der LE Baars JW Prins MH van Oers MH Rituximab treatment results in impaired secondary humoral immune responsiveness Blood 2002, 100:2257-2259. 12200395
29. Sarrecchia C Cappelli A Aiello P HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb J Infect Chemother 2005, 11:189-191. 10.1007/s10156-005-0385-z 16133710
30. Tsutsumi Y Kanamori H Mori A Tanaka J Asaka M Imamura M Masauzi N Reactivation of hepatitis B virus with rituximab Expert Opin Drug Saf 2005, 4:599-608. 10.1517/14740338.4.3.599 15934864
31. Kami M Hamaki T Murashige N Kishi Y Kusumi E Yuji K Miyakoshi S Ueyama J Morinaga S Mutou Y Safety of rituximab in lymphoma patients with hepatitis B or hepatitis C virus infection Hematol J 2003, 4:159-162. 10.1038/sj.thj.6200243 12750737
32. Perceau G Diris N Estines O Derancourt C Lévy S Bernard P Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma Br J Dermatol 2006, 155:1053-1056. 10.1111/j.1365-2133.2006.07451.x; 17034541
33. Dai MS Chao TY Kao WY Shyu RY Liu TM Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP Ann Hematol 2004, 83:769-774. 10.1007/s00277-004-0899-y 15338194
34. Visco C Arcaini L Brusamolino E Burcheri S Ambrosetti A Merli M Bonoldi E Chilosi M Viglio A Lazzarino M Pizzolo G Rodeghiero F Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: Analysis of 156 patients from northern Italy Ann Oncol 2006, 17:1434-1440. 10.1093/annonc/mdl131 16766591